Skip to content

Brian Cullingford, M.D.

NPI 1033378088ActiveIndividual· Internal Medicine, Cardiovascular Disease· N Chelmsford, MA

Internal Medicine, Cardiovascular Disease (M.D.) in N Chelmsford, Massachusetts, trained at Georgetown University School of Medicine (class of 2007). Their prescriptions cost Medicare Part D more than their services did: $1,240,178 for 4,979 claims, against $169,153 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 3 companies reporting payments in 2025, $78.35 in all, mostly food and beverage.

Overview

NPI1033378088
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedJun 5, 2008
Last updated in NPPESOct 3, 2016

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Cardiovascular Disease Primary207RC0000X258302MA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Cardiovascular Disease (Cardiology) (MA)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients1,353
Services billed3,212 across 51 procedure codes
Paid by Medicare$169,153

Part D prescriptions in 2024

Prescriptions (claims)4,979 · 12,372 30-day fills
Patients655
Total drug cost$1,240,178
Generic share79% of claims

Medicare sources and data years

Education and affiliations

Medical schoolGeorgetown University School of Medicine
Graduation year2007
Medicare specialtyCardiovascular Disease (Cardiology)
Secondary specialtiesInternal Medicine

Medical group

Hospital affiliations

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$78.35 · 3 payments from 3 companies
  • 2024$44.40 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Astrazeneca Pharmaceuticals LP$31.001
Bridgebio Pharma, Inc.$29.701
Pfizer Inc.$17.651

What the 2025 payments were for

  • Food and Beverage$78.35 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Cardiovascular Disease providers in N Chelmsford

All Internal Medicine, Cardiovascular Disease providers in Massachusetts →